ID   PTPR2_HUMAN             Reviewed;        1015 AA.
AC   Q92932; E9PC57; Q8N4I5; Q92662; Q9Y4F8; Q9Y4I6;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   10-MAY-2017, entry version 160.
DE   RecName: Full=Receptor-type tyrosine-protein phosphatase N2;
DE            Short=R-PTP-N2;
DE            EC=3.1.3.-;
DE            EC=3.1.3.48 {ECO:0000305|PubMed:8798755};
DE   AltName: Full=Islet cell autoantigen-related protein {ECO:0000303|PubMed:8798755};
DE            Short=IAR {ECO:0000303|PubMed:8798755};
DE            Short=ICAAR {ECO:0000303|PubMed:8954911};
DE   AltName: Full=Phogrin {ECO:0000303|PubMed:25421040, ECO:0000303|PubMed:8878534};
DE   Contains:
DE     RecName: Full=IA-2beta60;
DE   Flags: Precursor;
GN   Name=PTPRN2; Synonyms=KIAA0387;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), DOMAIN, ROLE IN DIABETES
RP   MELLITUS, AND VARIANT PRO-208.
RC   TISSUE=Pancreas;
RX   PubMed=8878534; DOI=10.1006/bbrc.1996.1526;
RA   Kawasaki E., Hutton J.C., Eisenbarth G.S.;
RT   "Molecular cloning and characterization of the human transmembrane
RT   protein tyrosine phosphatase homologue, phogrin, an autoantigen of
RT   type 1 diabetes.";
RL   Biochem. Biophys. Res. Commun. 227:440-447(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   VARIANT ASN-325.
RC   TISSUE=Fetal brain;
RX   PubMed=8954911; DOI=10.1006/bbrc.1996.1817;
RA   Smith P.D., Barker K.T., Wang J., Lu Y.-J., Shipley J., Crompton M.R.;
RT   "ICAAR, a novel member of a new family of transmembrane, tyrosine
RT   phosphatase-like proteins.";
RL   Biochem. Biophys. Res. Commun. 229:402-411(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, TISSUE SPECIFICITY, AND ROLE IN
RP   DIABETES MELLITUS.
RC   TISSUE=Brain, and Pancreas;
RX   PubMed=8798755; DOI=10.1074/jbc.271.40.24817;
RA   Cui L., Yu W.-P., de Aizpurua H.J., Schmidli R.S., Pallen C.J.;
RT   "Cloning and characterization of islet cell antigen-related protein-
RT   tyrosine phosphatase (PTP), a novel receptor-like PTP and autoantigen
RT   in insulin-dependent diabetes.";
RL   J. Biol. Chem. 271:24817-24823(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), AND VARIANTS THR-140; PRO-208
RP   AND ASN-325.
RC   TISSUE=Brain;
RA   Jiang S., Tulloch G., Fu Y., London R., Hummel G.S., White R.A.,
RA   Avraham H., Avraham S.;
RT   "Characterization and chromosomal localization of PTPRP, a receptor
RT   protein tyrosine phosphatase predominantly expressed in brain and
RT   pancreas.";
RL   Submitted (DEC-1996) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANTS
RP   PRO-208 AND HIS-213.
RC   TISSUE=Brain;
RX   PubMed=9205841; DOI=10.1093/dnares/4.2.141;
RA   Nagase T., Ishikawa K., Nakajima D., Ohira M., Seki N., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VII.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 4:141-150(1997).
RN   [6]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   PRO-208.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   DOMAIN, AND ROLE IN DIABETES MELLITUS.
RX   PubMed=8637868; DOI=10.1073/pnas.93.6.2307;
RA   Lu J., Li Q., Xie H., Chen Z.-J., Borovitskaya A.E., Maclaren N.K.,
RA   Notkins A.L., Lan M.S.;
RT   "Identification of a second transmembrane protein tyrosine
RT   phosphatase, IA-2beta, as an autoantigen in insulin-dependent diabetes
RT   mellitus: precursor of the 37-kDa tryptic fragment.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:2307-2311(1996).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-970, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   FUNCTION, AND MUTAGENESIS OF CYS-945.
RX   PubMed=26620550; DOI=10.15252/embj.201591973;
RA   Sengelaub C.A., Navrazhina K., Ross J.B., Halberg N., Tavazoie S.F.;
RT   "PTPRN2 and PLCbeta1 promote metastatic breast cancer cell migration
RT   through PI(4,5)P2-dependent actin remodeling.";
RL   EMBO J. 35:62-76(2016).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 715-1010.
RX   PubMed=19167335; DOI=10.1016/j.cell.2008.11.038;
RA   Barr A.J., Ugochukwu E., Lee W.H., King O.N.F., Filippakopoulos P.,
RA   Alfano I., Savitsky P., Burgess-Brown N.A., Mueller S., Knapp S.;
RT   "Large-scale structural analysis of the classical human protein
RT   tyrosine phosphatome.";
RL   Cell 136:352-363(2009).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 502-599.
RX   PubMed=25421040; DOI=10.1007/s10969-014-9191-0;
RA   Noguera M.E., Primo M.E., Jakoncic J., Poskus E., Solimena M.,
RA   Ermacora M.R.;
RT   "X-ray structure of the mature ectodomain of phogrin.";
RL   J. Struct. Funct. Genomics 16:1-9(2015).
RN   [14]
RP   VARIANT [LARGE SCALE ANALYSIS] LYS-716.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Plays a role in vesicle-mediated secretory processes.
CC       Required for normal accumulation of secretory vesicles in
CC       hippocampus, pituitary and pancreatic islets. Required for the
CC       accumulation of normal levels of insulin-containing vesicles and
CC       preventing their degradation. Plays a role in insulin secretion in
CC       response to glucose stimuli. Required for normal accumulation of
CC       the neurotransmitters norepinephrine, dopamine and serotonin in
CC       the brain. In females, but not in males, required for normal
CC       accumulation and secretion of pituitary hormones, such as
CC       luteinizing hormone (LH) and follicle-stimulating hormone (FSH)
CC       (By similarity). Required to maintain normal levels of renin
CC       expression and renin release (By similarity). May regulate
CC       catalytic active protein-tyrosine phosphatases such as PTPRA
CC       through dimerization (By similarity). Has phosphatidylinositol
CC       phosphatase activity; the PIPase activity is involved in its
CC       ability to regulate insulin secretion. Can dephosphorylate
CC       phosphatidylinositol 4,5-biphosphate (PI(4,5)P2),
CC       phosphatidylinositol 5-phosphate and phosphatidylinositol 3-
CC       phosphate (By similarity). Regulates PI(4,5)P2 level in the plasma
CC       membrane and localization of cofilin at the plasma membrane and
CC       thus is indirectly involved in regulation of actin dynamics
CC       related to cell migration and metastasis; upon hydrolyzation of
CC       PI(4,5)P2 cofilin is released from the plasma membrane and acts in
CC       the cytoplasm in severing F-actin filaments (PubMed:26620550).
CC       {ECO:0000250|UniProtKB:P80560, ECO:0000250|UniProtKB:Q63475,
CC       ECO:0000269|PubMed:26620550}.
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate. {ECO:0000255|PROSITE-ProRule:PRU10044,
CC       ECO:0000305|PubMed:8798755}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 4.5. {ECO:0000269|PubMed:8798755};
CC   -!- SUBUNIT: Self-associates. Interacts (via cytoplasmic domain) with
CC       PTPRN (via cytoplasmic domain). Interacts (precursor form) with
CC       CPE. Interacts with HAP1. Interacts with AP2A1 or AP2A2 and AP1G1;
CC       indicative for an association with adaptor protein complex 2 (AP-
CC       2) and adaptor protein complex 1 (AP-1) (By similarity). Interacts
CC       with AP2M1; indicative for an association with adaptor protein
CC       complex 2 (AP-2). Interacts with MYO5A (By similarity).
CC       {ECO:0000250|UniProtKB:P80560, ECO:0000250|UniProtKB:Q63475}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle
CC       membrane {ECO:0000250|UniProtKB:P80560}; Single-pass type I
CC       membrane protein {ECO:0000250|UniProtKB:P80560}. Cytoplasmic
CC       vesicle, secretory vesicle, synaptic vesicle membrane
CC       {ECO:0000250|UniProtKB:P80560}; Single-pass type I membrane
CC       protein {ECO:0000250|UniProtKB:P80560}. Note=Predominantly found
CC       on dense-core secretory granules. Sorting to secretory granules in
CC       part is dependent of the N-terminal propeptide domain of the
CC       precursor and its interaction with CPE (By similarity).
CC       Transiently found at the cell membrane, when secretory vesicles
CC       fuse with the cell membrane to release their cargo. Is then
CC       endocytosed and recycled to secretory vesicles involving clathrin-
CC       dependent AP2-mediated endocytosis. Recycled via STX6- but not
CC       TTTGN1/TGN38-containing compartments (By similarity).
CC       {ECO:0000250|UniProtKB:P80560, ECO:0000250|UniProtKB:Q63475}.
CC   -!- SUBCELLULAR LOCATION: IA-2beta60: Cytoplasmic vesicle, secretory
CC       vesicle membrane {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q92932-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q92932-2; Sequence=VSP_007779;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q92932-3; Sequence=VSP_035264;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q92932-4; Sequence=VSP_045032;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highest levels in brain and pancreas
CC       (PubMed:8954911, PubMed:8798755). Lower levels in trachea,
CC       prostate, stomach and spinal chord (PubMed:8798755).
CC       {ECO:0000269|PubMed:8798755, ECO:0000269|PubMed:8954911}.
CC   -!- DOMAIN: The cytoplasmic domain appears to contain the
CC       autoantigenic epitopes. {ECO:0000269|PubMed:8637868,
CC       ECO:0000269|PubMed:8878534}.
CC   -!- DOMAIN: The leucine-based sorting signal is proposed to function
CC       in trafficking at the plasma membrane.
CC       {ECO:0000250|UniProtKB:P80560}.
CC   -!- DOMAIN: The tyrosine-based internalization signal is proposed to
CC       function at the level of clathrin-mediated endocytosis and
CC       recycling. {ECO:0000250|UniProtKB:Q63475}.
CC   -!- PTM: Subject to proteolytic cleavage at multiple sites.
CC       {ECO:0000250|UniProtKB:P80560}.
CC   -!- DISEASE: Note=Autoantigen in insulin-dependent diabetes mellitus
CC       (IDDM). {ECO:0000269|PubMed:8637868, ECO:0000269|PubMed:8798755,
CC       ECO:0000269|PubMed:8878534}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Receptor class 8 subfamily. {ECO:0000305}.
CC   -!- CAUTION: Has no tyrosine-protein phosphatase activity at mild
CC       acidic conditions (pH 5.5). The in vivo relevance of the low PPase
CC       activity at acidic conditions (pH 4.5) is questioned. This
CC       catalytic activity seems to be affected by the replacement of a
CC       highly conserved residue in the tyrosine-protein phosphatase
CC       domain. {ECO:0000305, ECO:0000305|PubMed:8798755}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA20841.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U66702; AAC50742.1; -; mRNA.
DR   EMBL; Y08569; CAA69880.1; -; Genomic_DNA.
DR   EMBL; AF007555; AAB63600.1; -; mRNA.
DR   EMBL; U81561; AAB68603.1; -; mRNA.
DR   EMBL; AB002385; BAA20841.2; ALT_INIT; mRNA.
DR   EMBL; AC005481; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC006003; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC006372; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011899; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC019043; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC078942; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093662; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093856; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC125243; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC034040; AAH34040.1; -; mRNA.
DR   CCDS; CCDS5947.1; -. [Q92932-1]
DR   CCDS; CCDS5948.1; -. [Q92932-4]
DR   CCDS; CCDS5949.1; -. [Q92932-2]
DR   PIR; JC5062; JC5062.
DR   PIR; JC5263; JC5263.
DR   RefSeq; NP_001295196.1; NM_001308267.1.
DR   RefSeq; NP_001295197.1; NM_001308268.1. [Q92932-3]
DR   RefSeq; NP_002838.2; NM_002847.4. [Q92932-1]
DR   RefSeq; NP_570857.2; NM_130842.3. [Q92932-4]
DR   RefSeq; NP_570858.2; NM_130843.3. [Q92932-2]
DR   UniGene; Hs.490789; -.
DR   PDB; 2QEP; X-ray; 2.50 A; A/B=715-1010.
DR   PDB; 4HTI; X-ray; 1.95 A; A=502-599.
DR   PDB; 4HTJ; X-ray; 2.01 A; A=502-599.
DR   PDBsum; 2QEP; -.
DR   PDBsum; 4HTI; -.
DR   PDBsum; 4HTJ; -.
DR   ProteinModelPortal; Q92932; -.
DR   SMR; Q92932; -.
DR   BioGrid; 111763; 5.
DR   IntAct; Q92932; 7.
DR   MINT; MINT-1349716; -.
DR   STRING; 9606.ENSP00000374069; -.
DR   DEPOD; Q92932; -.
DR   iPTMnet; Q92932; -.
DR   PhosphoSitePlus; Q92932; -.
DR   BioMuta; PTPRN2; -.
DR   DMDM; 116242738; -.
DR   PaxDb; Q92932; -.
DR   PeptideAtlas; Q92932; -.
DR   PRIDE; Q92932; -.
DR   DNASU; 5799; -.
DR   Ensembl; ENST00000389413; ENSP00000374064; ENSG00000155093. [Q92932-2]
DR   Ensembl; ENST00000389416; ENSP00000374067; ENSG00000155093. [Q92932-4]
DR   Ensembl; ENST00000389418; ENSP00000374069; ENSG00000155093. [Q92932-1]
DR   GeneID; 5799; -.
DR   KEGG; hsa:5799; -.
DR   UCSC; uc003wno.4; human. [Q92932-1]
DR   CTD; 5799; -.
DR   DisGeNET; 5799; -.
DR   GeneCards; PTPRN2; -.
DR   H-InvDB; HIX0019047; -.
DR   HGNC; HGNC:9677; PTPRN2.
DR   HPA; HPA006900; -.
DR   HPA; HPA026656; -.
DR   MIM; 601698; gene.
DR   neXtProt; NX_Q92932; -.
DR   OpenTargets; ENSG00000155093; -.
DR   PharmGKB; PA34022; -.
DR   eggNOG; KOG0793; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   GeneTree; ENSGT00870000136478; -.
DR   HOGENOM; HOG000243992; -.
DR   HOVERGEN; HBG105788; -.
DR   InParanoid; Q92932; -.
DR   KO; K07817; -.
DR   OMA; EACVNDG; -.
DR   OrthoDB; EOG091G0LUR; -.
DR   PhylomeDB; Q92932; -.
DR   TreeFam; TF351976; -.
DR   BRENDA; 3.1.3.48; 2681.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   ChiTaRS; PTPRN2; human.
DR   EvolutionaryTrace; Q92932; -.
DR   GeneWiki; PTPRN2; -.
DR   GenomeRNAi; 5799; -.
DR   PRO; PR:Q92932; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000155093; -.
DR   CleanEx; HS_PTPRN2; -.
DR   ExpressionAtlas; Q92932; baseline and differential.
DR   Genevisible; Q92932; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; IEA:Ensembl.
DR   GO; GO:0101003; C:ficolin-1-rich granule membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0043235; C:receptor complex; IDA:MGI.
DR   GO; GO:0030667; C:secretory granule membrane; ISS:UniProtKB.
DR   GO; GO:0030672; C:synaptic vesicle membrane; ISS:UniProtKB.
DR   GO; GO:0043195; C:terminal bouton; IEA:Ensembl.
DR   GO; GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; TAS:ProtInc.
DR   GO; GO:0035773; P:insulin secretion involved in cellular response to glucose stimulus; ISS:UniProtKB.
DR   GO; GO:0006629; P:lipid metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0034260; P:negative regulation of GTPase activity; IEA:Ensembl.
DR   GO; GO:0007269; P:neurotransmitter secretion; ISS:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0006470; P:protein dephosphorylation; TAS:ProtInc.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR033522; IA-2/IA-2_beta.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR021613; Receptor_IA-2_dom.
DR   InterPro; IPR029403; RESP18_dom.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   PANTHER; PTHR19134:SF418; PTHR19134:SF418; 1.
DR   Pfam; PF11548; Receptor_IA-2; 1.
DR   Pfam; PF14948; RESP18; 1.
DR   Pfam; PF00102; Y_phosphatase; 1.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00194; PTPc; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell junction;
KW   Complete proteome; Cytoplasmic vesicle; Diabetes mellitus;
KW   Glycoprotein; Hydrolase; Lipid metabolism; Membrane;
KW   Phospholipid metabolism; Phosphoprotein; Polymorphism;
KW   Protein phosphatase; Receptor; Reference proteome; Signal; Synapse;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     21       {ECO:0000255}.
FT   CHAIN        22   1015       Receptor-type tyrosine-protein
FT                                phosphatase N2.
FT                                /FTId=PRO_0000025454.
FT   CHAIN       502   1015       IA-2beta60.
FT                                {ECO:0000250|UniProtKB:P80560,
FT                                ECO:0000250|UniProtKB:Q63475}.
FT                                /FTId=PRO_0000438088.
FT   TOPO_DOM     22    615       Extracellular. {ECO:0000255}.
FT   TRANSMEM    616    636       Helical. {ECO:0000255}.
FT   TOPO_DOM    637   1015       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      745   1005       Tyrosine-protein phosphatase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160}.
FT   REGION        1    421       Involved in localization to secretory
FT                                granules; interaction with CPE.
FT                                {ECO:0000250|UniProtKB:P80560}.
FT   REGION      945    951       Substrate binding. {ECO:0000250}.
FT   MOTIF       666    675       Tyrosine-based internalization motif.
FT                                {ECO:0000250|UniProtKB:Q63475}.
FT   MOTIF      1004   1010       Leucine-based sorting signal.
FT                                {ECO:0000250|UniProtKB:P80560}.
FT   ACT_SITE    945    945       Phosphocysteine intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160,
FT                                ECO:0000255|PROSITE-ProRule:PRU10044}.
FT   BINDING     913    913       Substrate. {ECO:0000250}.
FT   BINDING     990    990       Substrate. {ECO:0000250}.
FT   SITE        427    428       Cleavage. {ECO:0000255}.
FT   MOD_RES     436    436       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P80560}.
FT   MOD_RES     437    437       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P80560}.
FT   MOD_RES     692    692       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P80560}.
FT   MOD_RES     698    698       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q63475}.
FT   MOD_RES     970    970       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   CARBOHYD    564    564       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1     37       MGPPLPLLLLLLLLLPPRVLPAAPSSVPRGRQLPGRL ->
FT                                MAVESEYSLLRTEASFPTMKMFCVSHTLPRVEVMFVSGPQT
FT                                RERTEPVDPRWQCLVQMWA (in isoform 3).
FT                                {ECO:0000303|PubMed:9205841}.
FT                                /FTId=VSP_035264.
FT   VAR_SEQ      38     54       Missing (in isoform 4).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_045032.
FT   VAR_SEQ     519    547       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_007779.
FT   VARIANT     140    140       S -> T (in dbSNP:rs3800855).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_027955.
FT   VARIANT     208    208       S -> P (in dbSNP:rs1130495).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:8878534,
FT                                ECO:0000269|PubMed:9205841,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_046301.
FT   VARIANT     213    213       R -> H (in dbSNP:rs1130496).
FT                                {ECO:0000269|PubMed:9205841}.
FT                                /FTId=VAR_027956.
FT   VARIANT     325    325       S -> N (in dbSNP:rs1130499).
FT                                {ECO:0000269|PubMed:8954911,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_020302.
FT   VARIANT     343    343       V -> M (in dbSNP:rs3752368).
FT                                /FTId=VAR_022015.
FT   VARIANT     388    388       L -> H (in dbSNP:rs7456452).
FT                                /FTId=VAR_046302.
FT   VARIANT     716    716       E -> K (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs577236042).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035648.
FT   MUTAGEN     945    945       C->A: No effect to increase invasion,
FT                                migration, and metastatic lung
FT                                colonization in mice breast cancer model.
FT                                {ECO:0000269|PubMed:26620550}.
FT   MUTAGEN     945    945       C->S: Loss of activity.
FT   CONFLICT    160    160       A -> D (in Ref. 4; AAB68603).
FT                                {ECO:0000305}.
FT   CONFLICT    247    247       S -> G (in Ref. 2; CAA69880).
FT                                {ECO:0000305}.
FT   CONFLICT    323    323       G -> R (in Ref. 2; CAA69880).
FT                                {ECO:0000305}.
FT   STRAND      512    517       {ECO:0000244|PDB:4HTI}.
FT   HELIX       523    536       {ECO:0000244|PDB:4HTI}.
FT   HELIX       541    543       {ECO:0000244|PDB:4HTI}.
FT   STRAND      544    550       {ECO:0000244|PDB:4HTI}.
FT   STRAND      553    558       {ECO:0000244|PDB:4HTI}.
FT   HELIX       567    576       {ECO:0000244|PDB:4HTI}.
FT   HELIX       578    585       {ECO:0000244|PDB:4HTI}.
FT   STRAND      589    594       {ECO:0000244|PDB:4HTI}.
FT   HELIX       725    738       {ECO:0000244|PDB:2QEP}.
FT   HELIX       742    754       {ECO:0000244|PDB:2QEP}.
FT   TURN        763    766       {ECO:0000244|PDB:2QEP}.
FT   TURN        768    770       {ECO:0000244|PDB:2QEP}.
FT   HELIX       771    773       {ECO:0000244|PDB:2QEP}.
FT   HELIX       783    785       {ECO:0000244|PDB:2QEP}.
FT   TURN        791    793       {ECO:0000244|PDB:2QEP}.
FT   STRAND      795    797       {ECO:0000244|PDB:2QEP}.
FT   STRAND      802    806       {ECO:0000244|PDB:2QEP}.
FT   STRAND      811    813       {ECO:0000244|PDB:2QEP}.
FT   STRAND      815    819       {ECO:0000244|PDB:2QEP}.
FT   HELIX       824    826       {ECO:0000244|PDB:2QEP}.
FT   HELIX       827    836       {ECO:0000244|PDB:2QEP}.
FT   STRAND      841    844       {ECO:0000244|PDB:2QEP}.
FT   STRAND      848    850       {ECO:0000244|PDB:2QEP}.
FT   STRAND      862    868       {ECO:0000244|PDB:2QEP}.
FT   STRAND      871    882       {ECO:0000244|PDB:2QEP}.
FT   STRAND      885    894       {ECO:0000244|PDB:2QEP}.
FT   TURN        895    898       {ECO:0000244|PDB:2QEP}.
FT   STRAND      899    908       {ECO:0000244|PDB:2QEP}.
FT   HELIX       920    934       {ECO:0000244|PDB:2QEP}.
FT   STRAND      941    944       {ECO:0000244|PDB:2QEP}.
FT   STRAND      946    949       {ECO:0000244|PDB:2QEP}.
FT   HELIX       950    966       {ECO:0000244|PDB:2QEP}.
FT   HELIX       974    982       {ECO:0000244|PDB:2QEP}.
FT   HELIX       992   1010       {ECO:0000244|PDB:2QEP}.
SQ   SEQUENCE   1015 AA;  111271 MW;  950C15CA89DBC029 CRC64;
     MGPPLPLLLL LLLLLPPRVL PAAPSSVPRG RQLPGRLGCL LEEGLCGASE ACVNDGVFGR
     CQKVPAMDFY RYEVSPVALQ RLRVALQKLS GTGFTWQDDY TQYVMDQELA DLPKTYLRRP
     EASSPARPSK HSVGSERRYS REGGAALANA LRRHLPFLEA LSQAPASDVL ARTHTAQDRP
     PAEGDDRFSE SILTYVAHTS ALTYPPGSRT QLREDLLPRT LGQLQPDELS PKVDSGVDRH
     HLMAALSAYA AQRPPAPPGE GSLEPQYLLR APSRMPRPLL APAAPQKWPS PLGDSEDPSS
     TGDGARIHTL LKDLQRQPAE VRGLSGLELD GMAELMAGLM QGVDHGVARG SPGRAALGES
     GEQADGPKAT LRGDSFPDDG VQDDDDRLYQ EVHRLSATLG GLLQDHGSRL LPGALPFARP
     LDMERKKSEH PESSLSSEEE TAGVENVKSQ TYSKDLLGQQ PHSEPGAAAF GELQNQMPGP
     SKEEQSLPAG AQEALSDGLQ LEVQPSEEEA RGYIVTDRDP LRPEEGRRLV EDVARLLQVP
     SSAFADVEVL GPAVTFKVSA NVQNVTTEDV EKATVDNKDK LEETSGLKIL QTGVGSKSKL
     KFLPPQAEQE DSTKFIALTL VSLACILGVL LASGLIYCLR HSSQHRLKEK LSGLGGDPGA
     DATAAYQELC RQRMATRPPD RPEGPHTSRI SSVSSQFSDG PIPSPSARSS ASSWSEEPVQ
     SNMDISTGHM ILSYMEDHLK NKNRLEKEWE ALCAYQAEPN SSFVAQREEN VPKNRSLAVL
     TYDHSRVLLK AENSHSHSDY INASPIMDHD PRNPAYIATQ GPLPATVADF WQMVWESGCV
     VIVMLTPLAE NGVRQCYHYW PDEGSNLYHI YEVNLVSEHI WCEDFLVRSF YLKNLQTNET
     RTVTQFHFLS WYDRGVPSSS RSLLDFRRKV NKCYRGRSCP IIVHCSDGAG RSGTYVLIDM
     VLNKMAKGAK EIDIAATLEH LRDQRPGMVQ TKEQFEFALT AVAEEVNAIL KALPQ
//
